Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.46 USD | +0.81% | -0.40% | -27.01% |
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- The company is in debt and has limited leeway for investment
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 93.25 times its estimated earnings per share for the ongoing year.
- The company's enterprise value to sales, at 4.06 times its current sales, is high.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Investment Management & Fund Operators
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-27.01% | 843M | C- | ||
+4.75% | 8.74B | B+ | ||
+13.83% | 3.48B | C- | ||
-36.31% | 2.96B | B | ||
+13.29% | 2.52B | B- | ||
+14.51% | 2.39B | C | ||
+42.63% | 2.17B | - | - | |
+9.13% | 1.42B | B+ | ||
+17.41% | 1.49B | B- | ||
+12.44% | 1.49B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- PX Stock
- Ratings P10, Inc.